FlexTrade Systems, a global provider of multi-asset execution management system (EMS) technology, today announced that it will stream relevant research data from institutional research provider RSRCHXchange (RSRCHX) through the FlexTRADER EMS platform, according to an official company statement regarding the deal.
Announced from the company’s London office, the synergy is aimed to help buy-side traders that are using the FlexTRADER EMS with relevant market information and research available in the RSRCHX marketplace and while complying with MiFID II unbundling mandates related to how funds are used to pay for research.
FlexTRADER’s integration with RSRCHX allows traders to actively monitor research from a variety of providers directly from their trading blotter.
Streamlining institutional research
Vicky Sanders, co-founder of RSRCHXchange, added in the statement: “We are delighted to be working with FlexTrade to offer its buy-side clients access to a wide array of research from leading providers. By using our RSRCHX platform, FlexTrade’s buy-side traders can alert their portfolio managers to the availability of new, relevant research.”
Mrs. Sanders added: “This partnership expands our growing client base and we look forward to working with FlexTrade and its customers in the future.”
ACY Securities Supports ASIC’s Product Intervention OrderGo to article >>
Initially launched just last September, the RSRCHX platform was tailored to meet the needs of asset managers and research providers with new approaches to how financial investment research data is procured and distributed.
Tailored to comply with MiFID II
For example, the platform allows asset managers to track how research is consumed across all staff, while improving the procurement process and helping firms to prepare for MiFID II unbundling requirements, as per the official statement.
Commenting in the company statement, Andy Mahoney, Director of Business Development for FlexTrade UK in London, said: “FlexTRADER’s integration with RSRCHX allows traders to actively monitor research from a variety of providers directly from their trading blotter. This integration adds an integral piece of FlexTrade’s strategic direction around regulation, in particular, providing compliance with the unbundling of research costs required by MiFID II.”
Mr. Mahoney added: “We have integrated with bank research portals in the past, but RSRCHXchange provides the perfect platform to access research from many different providers, in an unbundled, MiFID II compliant manner.”